Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Cells|November 26, 2022
Advances in T Cells Based on Inflammation in Metabolic DiseasesWenlu Yu, Chunxiu Li, Deju Zhang, et al.Frontiers in Endocrinology|January 23, 2023
A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learningZiye Wang, Chan Xu, Wencai Liu, et al.Cell Death & Disease|February 11, 2023
Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategiesXinyue Chen, Qi Cai, Ruikai Liang, et al.Frontiers of Medicine|June 26, 2024
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancerYuanxin Yao, Honghui Lv, Meiying Zhang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2023
Regulation of NcRNA-protein binding in diabetic footYujia Zhang, Jing Zhang, Zhou Xu, et al.Theranostics|May 17, 2021
KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1Wenxue Liu, Zhiyan Zhan, Meiying Zhang, et al.Elife|May 4, 2019
PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitorsKaixuan Shi, Xia Yin, Mei-Chun Cai, et al.Frontiers in Genetics|November 5, 2025
A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing of its antisense lncRNA in colon cancerXuming Hu, Ye Wei, Meiying Zhang, et al.Neurology|July 8, 2021
Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia GravisZheng Yu, Meiying Zhang, Hongyang Jing, et al.European Journal of Medicinal Chemistry|November 26, 2023
Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemiaWenyan Liu, Yu Bai, Licheng Zhou, et al.Pageof 11